CN1993355A - 奥美沙坦酯的纯化方法 - Google Patents

奥美沙坦酯的纯化方法 Download PDF

Info

Publication number
CN1993355A
CN1993355A CNA2005800262573A CN200580026257A CN1993355A CN 1993355 A CN1993355 A CN 1993355A CN A2005800262573 A CNA2005800262573 A CN A2005800262573A CN 200580026257 A CN200580026257 A CN 200580026257A CN 1993355 A CN1993355 A CN 1993355A
Authority
CN
China
Prior art keywords
solution
acid
olmesartan medoxomill
water
olmesartan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800262573A
Other languages
English (en)
Chinese (zh)
Inventor
L·赫德瓦蒂
G·皮拉斯基
Y·赖兹
E·马罗姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of CN1993355A publication Critical patent/CN1993355A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2005800262573A 2004-09-02 2005-09-02 奥美沙坦酯的纯化方法 Pending CN1993355A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60643704P 2004-09-02 2004-09-02
US60/606,437 2004-09-02
US60/638,736 2004-12-22

Publications (1)

Publication Number Publication Date
CN1993355A true CN1993355A (zh) 2007-07-04

Family

ID=35462159

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA2005800262573A Pending CN1993355A (zh) 2004-09-02 2005-09-02 奥美沙坦酯的纯化方法
CNA2005800219037A Pending CN1976926A (zh) 2004-09-02 2005-09-02 奥美沙坦酯的制备

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA2005800219037A Pending CN1976926A (zh) 2004-09-02 2005-09-02 奥美沙坦酯的制备

Country Status (7)

Country Link
US (1) US7528258B2 (enExample)
EP (1) EP1706401A1 (enExample)
JP (1) JP4511550B2 (enExample)
CN (2) CN1993355A (enExample)
CA (1) CA2573800A1 (enExample)
IL (1) IL181549A0 (enExample)
WO (1) WO2006029056A1 (enExample)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102414200A (zh) * 2009-04-28 2012-04-11 第一三共株式会社 奥美沙坦酯的制备方法
CN102414201A (zh) * 2009-04-28 2012-04-11 第一三共株式会社 新型溶剂化物晶体
CN102459243A (zh) * 2009-05-20 2012-05-16 兰贝克赛实验室有限公司 奥美沙坦酯制造工艺
CN102558161A (zh) * 2011-12-07 2012-07-11 浙江华海药业股份有限公司 一种采用丙酮与水混合液精制奥美沙坦酯的工艺
CN102584804A (zh) * 2011-12-13 2012-07-18 浙江华海药业股份有限公司 一种三苯甲基奥美沙坦酯脱保护基制备奥美沙坦酯的工艺
US8735598B2 (en) 2008-06-09 2014-05-27 Daiichi Sankyo Company, Limited Method for producing 1-biphenylmethylimidazole compound
US9034874B2 (en) 2012-07-20 2015-05-19 Novartis Ag Carbamate/urea derivatives
CN108658954A (zh) * 2018-06-12 2018-10-16 广州小桔生物科技有限公司 一种高纯度奥美沙坦酯的精制方法
CN109761966A (zh) * 2019-01-30 2019-05-17 浙江省食品药品检验研究院 一种奥美沙坦酯晶体及其制备方法

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060281800A1 (en) * 2005-04-12 2006-12-14 Glenmark Pharmaceuticals Limited Polymorphic form of olmesartan and process for its preparation
EP1816131A1 (en) * 2006-02-06 2007-08-08 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of olmesartan medoxomil
EP1910343B1 (en) * 2005-07-29 2014-10-29 Krka Process for the preparation of olmesartan medoxomil
JP2010535743A (ja) * 2007-08-08 2010-11-25 レツク・フアーマシユーテイカルズ・デー・デー オルメサルタンメドキソミルの調製のための方法
EP2022790A1 (en) * 2007-08-08 2009-02-11 LEK Pharmaceuticals D.D. A process for the preparation or purification of olmesartan medoxomil
WO2011014611A2 (en) * 2009-07-30 2011-02-03 Dr. Reddy's Laboratories Ltd. Preparation of olmesartan medoxomil
WO2011013096A1 (en) * 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Polymorphic form of olmesartan medoxomil
EP2409710A1 (en) 2010-06-29 2012-01-25 NanotecMARIN GmbH Injectable material and material to be used as drug or food supplement for prophylaxis or treatment of osteoporosis
EP2409682A1 (en) 2010-07-19 2012-01-25 Werner E. G. MÜLLER Hydroxyapatite-binding nano- and microparticles for caries prophylaxis and reduction of dental hypersensitivity
KR101266224B1 (ko) 2010-09-02 2013-05-21 일동제약주식회사 트리틸 올메사르탄 메독소밀의 개선된 제조방법
AR083523A1 (es) 2010-10-29 2013-03-06 Interquim Sa Procedimiento de obtencion del olmesartan medoxomilo
CZ2010785A3 (cs) * 2010-10-29 2012-05-16 Zentiva, K.S. Zpusob výroby olmesartanu medoxomilu
EP2489346A1 (en) 2011-01-26 2012-08-22 NanotecMARIN GmbH Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
MX2014001298A (es) 2011-08-05 2014-09-01 Lupin Ltd Procedimiento para la preparacion de olmesartan medoxomilo.
WO2014036686A1 (zh) * 2012-09-04 2014-03-13 上海迪赛诺化学制药有限公司 奥美沙坦酯的制备方法
CN111170946B (zh) * 2020-03-16 2022-02-11 浙江华洲药业有限公司 一种奥美沙坦中间体的合成方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
DE3634717A1 (de) * 1986-10-11 1988-04-14 Dynamit Nobel Ag Verfahren zur herstellung von 5-methyltetrazol
US4870188A (en) 1987-04-16 1989-09-26 Neorx Corporation Vinyl substituted radiohalogen conjugates for protein labeling
US4870186A (en) * 1987-05-22 1989-09-26 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
DE4036706A1 (de) * 1990-11-17 1992-05-21 Hoechst Ag Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
US5656650A (en) * 1990-12-14 1997-08-12 Smithkline Beecham Corp. Angiotensin II receptor blocking compositions
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process
US5591762A (en) * 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
CA2229000C (en) * 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
US5252753A (en) * 1991-11-01 1993-10-12 Ortho Pharmaceutical Corporation Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof
US5310928A (en) * 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
US5264447A (en) * 1992-09-01 1993-11-23 Merck & Co., Inc. Angiotensin II antagonist
JPH06298683A (ja) 1993-04-15 1994-10-25 Sankyo Co Ltd 光反応による４−（２−置換）フェニルベンジルブロミド類の製造法
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
JPH0753489A (ja) 1993-06-11 1995-02-28 Sankyo Co Ltd ビフェニルカルボキサミド誘導体の製造法
US5412102A (en) 1994-05-27 1995-05-02 Syntex (U.S.A.) Inc. Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid
JP2928982B2 (ja) * 1994-10-27 1999-08-03 住化ファインケム株式会社 ４’−ブロモメチル−２−シアノビフェニルの製造法
JPH08325248A (ja) 1995-05-26 1996-12-10 Chugoku Kayaku Kk テトラゾール類の新規な合成試薬及びそれを用いたテトラゾール類の製造方法
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
JP3671266B2 (ja) * 1996-03-21 2005-07-13 東洋化成工業株式会社 ５−置換テトラゾール類の製造方法
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
IT1291551B1 (it) * 1997-04-11 1999-01-11 Luso Farmaco Inst Processo per la preparazione di composti 4-bromometil bifenilici
FR2771090B1 (fr) * 1997-11-17 2000-02-04 Sanofi Sa Procede de preparation de derives de bromomethyl-biphenyle
DE19757995A1 (de) 1997-12-29 1999-07-08 Great Lakes Chem Konstanz Gmbh Verfahren zur Herstellung von aromatischen Brommethyl-Verbindungen
JP4185182B2 (ja) 1998-04-08 2008-11-26 第一三共株式会社 イミダゾール誘導体の製造方法
JP4260241B2 (ja) 1998-04-21 2009-04-30 第一三共株式会社 イミダゾール誘導体の製造法
US6271418B1 (en) * 2000-02-22 2001-08-07 Nippon Kayaku Co., Ltd. Process for preparing (hetero) aromatic substituted benzene derivatives
PT1336407E (pt) * 2000-11-21 2006-07-31 Sankyo Co Composicao contendo um antagonista do receptor de angiotensina e um diuretico e sua utilizacao para o tratamento da hipertensao
ES2299616T3 (es) * 2002-06-12 2008-06-01 Sumitomo Chemical Company, Limited Procedimiento para producir 4'-bromometil-2-cianobifelino.
CN1271068C (zh) 2003-03-25 2006-08-23 上海医药工业研究院 一种奥美沙坦酯的制备方法
ITMI20032338A1 (it) * 2003-11-28 2005-05-29 Dinamite Dipharma S P A In Forma A Bbreviata Diph Composti feniltetrazolici.

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8735598B2 (en) 2008-06-09 2014-05-27 Daiichi Sankyo Company, Limited Method for producing 1-biphenylmethylimidazole compound
CN102414201B (zh) * 2009-04-28 2015-10-14 第一三共株式会社 溶剂化物晶体
CN102414201A (zh) * 2009-04-28 2012-04-11 第一三共株式会社 新型溶剂化物晶体
CN102414200A (zh) * 2009-04-28 2012-04-11 第一三共株式会社 奥美沙坦酯的制备方法
US8859600B2 (en) 2009-04-28 2014-10-14 Daiichi Sankyo Company, Limited Acetone solvate crystals of trityl olmesartan medoxomil
CN102414200B (zh) * 2009-04-28 2014-12-17 第一三共株式会社 奥美沙坦酯的制备方法
US8933241B2 (en) 2009-04-28 2015-01-13 Daiichi Sankyo Company, Limited Method for producing olmesartan medoxomil
CN102459243A (zh) * 2009-05-20 2012-05-16 兰贝克赛实验室有限公司 奥美沙坦酯制造工艺
CN102558161A (zh) * 2011-12-07 2012-07-11 浙江华海药业股份有限公司 一种采用丙酮与水混合液精制奥美沙坦酯的工艺
CN102558161B (zh) * 2011-12-07 2016-07-06 浙江华海药业股份有限公司 一种采用丙酮与水混合液精制奥美沙坦酯的工艺
CN102584804A (zh) * 2011-12-13 2012-07-18 浙江华海药业股份有限公司 一种三苯甲基奥美沙坦酯脱保护基制备奥美沙坦酯的工艺
CN102584804B (zh) * 2011-12-13 2016-05-18 浙江华海药业股份有限公司 一种三苯甲基奥美沙坦酯脱保护基制备奥美沙坦酯的工艺
US9273026B2 (en) 2012-07-20 2016-03-01 Novartis Ag Carbamate/urea derivatives
US9034874B2 (en) 2012-07-20 2015-05-19 Novartis Ag Carbamate/urea derivatives
US9624192B2 (en) 2012-07-20 2017-04-18 Novartis Ag Carbamate/urea derivatives
CN108658954A (zh) * 2018-06-12 2018-10-16 广州小桔生物科技有限公司 一种高纯度奥美沙坦酯的精制方法
CN109761966A (zh) * 2019-01-30 2019-05-17 浙江省食品药品检验研究院 一种奥美沙坦酯晶体及其制备方法

Also Published As

Publication number Publication date
US7528258B2 (en) 2009-05-05
CA2573800A1 (en) 2006-03-16
US20060069141A1 (en) 2006-03-30
EP1706401A1 (en) 2006-10-04
JP2007509992A (ja) 2007-04-19
CN1976926A (zh) 2007-06-06
IL181549A0 (en) 2007-07-04
JP4511550B2 (ja) 2010-07-28
WO2006029056A1 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
JP4437141B2 (ja) オルメサルタンメドキソミルの精製法
US7528258B2 (en) Preparation of olmesartan medoxomil
CN1575287A (zh) 乙酰替苯胺衍生物的α型或β型结晶
US8288401B2 (en) Polymorphic forms
WO2012090043A1 (en) Novel solid state forms of azilsartan medoxomil and preparation thereof
CN1578772A (zh) 太尔密沙登的晶状钠盐及其作为血管紧张素的拮抗药的用途
CN1898211A (zh) 喹啉化合物的晶形及其生产方法
JP5944539B2 (ja) 新規溶媒和物結晶およびその製造方法
CN102414200B (zh) 奥美沙坦酯的制备方法
US20070054948A1 (en) Purification of olmesartan medoxomil
CN1498216A (zh) 新的奥丹西隆盐酸盐晶体和溶剂化物及其制备方法
JP5455905B2 (ja) 新規結晶形態
CN101133020A (zh) 依泽替米贝多晶型
JP2008525531A (ja) セフジニルカリウム塩の結晶形
CN1950331A (zh) 那格列奈的多晶型物
CN102459243A (zh) 奥美沙坦酯制造工艺
KR100912214B1 (ko) 세프디니르 세슘 염의 결정형
CN1681803A (zh) 芳酰基－哌啶衍生物
CN1880294A (zh) 右酮洛芬氨丁三醇的多晶型、其制备方法和包含它的组合物
JP3931884B2 (ja) 錠剤の製造方法
CN1906175A (zh) 罗苏伐他汀的结晶铵盐
WO2025141465A1 (en) Solid state forms of zipalertinib hydrochloride and process for preparation thereof
WO2025141467A1 (en) Solid state forms of lorundrostat and process thereof
JP3900302B2 (ja) 結晶性ｌ−アスパラギン酸カルシウムの製造方法
EP1931648A2 (en) Processes for the synthesis of 5-phenyl -1 trityl-1h-tetrazole

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication